Validation of a chloroquine-induced cell death mechanism for clinical use against malaria.
An alternative antimalarial pathway of an 'outdated' drug, chloroquine (CQ), may facilitate its return to the shrinking list of effective antimalarials. Conventionally, CQ is believed to interfere with hemozoin formation at nanomolar concentrations, but resistant parasites are able to effl...
Autori principali: | Ch'ng, J, Lee, Y, Gun, S, Chia, W, Chang, Z, Wong, L, Batty, K, Russell, B, Nosten, F, Renia, L, Tan, K |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Nature Publishing Group
2014
|
Soggetti: |
Documenti analoghi
Documenti analoghi
-
Evaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia
di: Sutanto, I, et al.
Pubblicazione: (2010) -
A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria
di: Ch'Ng, J, et al.
Pubblicazione: (2013) -
PLASMODIUM VIVAX MALARIA: CLINICAL COURSE AND FREQUENCY OF RESISTANCE AGAINST CHLOROQUINE
di: Muhammad Asif Nizami, et al.
Pubblicazione: (2021-02-01) -
Microbial hara-kiri: Exploiting lysosomal cell death in malaria parasites
di: Jun-Hong Ch’ng, et al.
Pubblicazione: (2015-01-01) -
Leveraging the effects of chloroquine on resistant malaria parasites for combination therapies
di: Ana M. Untaroiu, et al.
Pubblicazione: (2019-04-01)